Anteris Technologies (AU:AVR) has released an update.
Anteris Technologies Ltd is set to re-domicile to the United States, aiming to establish itself as the parent company of the Anteris Group through a newly-formed Delaware corporation. The move includes a strategic plan to list on the Nasdaq and conduct an Initial Public Offering (IPO) primarily targeted at the US market, with funds raised to support the development of its innovative heart valve technology and related clinical trials. This transition to the US is anticipated to enhance the company’s access to capital, visibility, and potential for future strategic partnerships.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.
